Takashi Kurosaki

Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade

S. Tomida, J. Tanizaki, R. Hatae, 2024, The Journal of clinical investigation.

Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study

Y. Nishimura, Kaoru Tanaka, K. Doi, 2020, Anti-cancer drugs.

Association of tumour burden with the efficacy of programmed cell death-1/programmed cell death ligand-1 inhibitors for treatment-naïve advanced non-small-cell lung cancer.

Kaoru Tanaka, K. Nishio, Y. Hasegawa, 2021, European journal of cancer.